Home Newsletters Dermal Cell News ACA-28, an ERK MAPK Signaling Modulator, Exerts Anticancer Activity through ROS Induction...

ACA-28, an ERK MAPK Signaling Modulator, Exerts Anticancer Activity through ROS Induction in Melanoma and Pancreatic Cancer Cells

0
Investigators performed a global gene expression analysis of human melanoma cells exposed to ACA-28 using a DNA microarray to comprehensively understand the biological cellular impact induced by ACA-28.
[Oxidative Medicine And Cellular Longevity]
Full Article
Exit mobile version